Stocks and Investing Stocks and Investing
Fri, August 28, 2020

Tiago Fauth Maintained (ASND) at Buy with Increased Target to $158 on, Aug 28th, 2020


Published on 2024-10-27 12:44:16 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $154 to $158 on, Aug 28th, 2020.

Tiago has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Tiago


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $177 on, Wednesday, July 15th, 2020
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $173 on, Wednesday, May 20th, 2020
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $208 on, Wednesday, May 20th, 2020

Contributing Sources